BGN Technologies and the Ben-Gurion Model
BGN Technologies — commercialization arm of Ben-Gurion University of the Negev. Beer-Sheva's answer to Yissum and Ramot. NeuroDerm's $1.1B Mitsubishi Tanabe exit is the evidence. CyberSpark is the geography. The academic anchor of the Negev cyber and desert-innovation cluster.
BGN Technologies and the Ben-Gurion Model
BGN Technologies is the commercialization arm of Ben-Gurion University of the Negev — the office that turned desert research into NeuroDerm, AlgaTech, and the anchor academic layer of Beer-Sheva's cyber cluster. The Negev's answer to Yissum and Ramot.
What BGN Is
B.G. Negev Technologies and Applications Ltd. — trading as BGN Technologies — is the technology-transfer arm of Ben-Gurion University of the Negev (BGU). Headquartered inside BGU's Advanced Technologies Park in Beer-Sheva. Legal owner of the university's patent portfolio. Executor of every commercial license, sponsored-research agreement, and spinout formed on BGU IP.
The fourth of Israel's four flagship tech-transfer offices — after Yissum (Hebrew University, 1964), Yeda (Weizmann Institute, 1959), and Ramot (Tel Aviv University, 1973). BGN is the Southern node. The Negev's version of the same institutional model.
CEO: Netta Cohen. President of BGU: Prof. Daniel Chamovitz. Board chair: Gil Weiser.
The Scale
Roughly 100+ spinout companies formed on BGU IP over the office's operating history. Active industry-funded research agreements with dozens of Israeli and international corporates. Long-term partnerships with Deutsche Telekom, Dell-EMC, Lockheed Martin, IBM, and PayPal — anchor sponsors that reflect the Negev's cyber, data, and homeland-security tilt.
Ben-Gurion University ranks inside PitchBook's top 100 universities globally for producing entrepreneurs. The only Israeli university on that list outside Tel Aviv and Jerusalem. That ranking is BGN's exit tape.
Fields Covered
- Cybersecurity — the largest cluster. BGU anchors the CyberSpark ecosystem in Beer-Sheva alongside the IDF's C4I and cyber campus (Camp Nathan), the National Cyber Directorate's presence, and the multinational R&D offices (Dell, Deutsche Telekom, Lockheed, IBM, PayPal) that sit in the same park.
- Biotechnology and pharma — drug delivery, immuno-oncology, vaccines, diabetes, cancer.
- Agtech and desert agriculture — the field where BGU has a natural comparative advantage no other Israeli university can match.
- Water, environmental, and alternative energy — arid-zone hydrology, solar, storage.
- Robotics, quantum, materials, nanotechnology, homeland security.
Anchor Spinouts
NeuroDerm. Developed a levodopa/carbidopa continuous-delivery skin patch for Parkinson's disease. Acquired by Mitsubishi Tanabe Pharma in 2017 for approximately $1.1 billion — the single largest exit ever traced to BGU research, and the piece of evidence that puts BGN on the same league table as Yissum and Ramot.
AlgaTech (Algatechnologies). Founded 1998. Cultivates microalgae in the Arava desert to produce natural astaxanthin and other nutraceutical ingredients. Acquired by Solabia Group in 2019. Category-defining position in astaxanthin.
NanoGhost. Ghost cell–based targeted drug delivery platform for oncology. Multiple Israel Innovation Authority grants; active collaboration with BGU labs.
Protea Vaccines. Universal protein-based Streptococcus pneumoniae vaccine, developed with Soroka University Medical Center. Absorbed into NasVax.
Cybersecurity spinouts. Multiple BGU-linked companies operating out of the Advanced Technologies Park and CyberSpark — the cluster that gives BGN its differentiated deal flow versus the Tel Aviv and Jerusalem offices.
What Makes BGN Structurally Different
Location is the differentiator. Yissum sits in Jerusalem. Yeda sits in Rehovot. Ramot sits in Tel Aviv. BGN sits in Beer-Sheva — inside the Advanced Technologies Park, adjacent to the IDF's cyber and intelligence campus, ten minutes from Soroka, and inside CyberSpark. No other Israeli tech-transfer office is embedded in a defense-intelligence cluster of that density.
Deal flow tilt. The result is a portfolio weighted toward cyber, defense-adjacent applications, homeland security, and desert-domain applied science (water, agtech, solar) — categories where BGU's research and its neighbors' procurement calendars line up.
Regional development mandate. BGN operates inside a national policy frame — Negev development — that the northern offices do not. State infrastructure investment in Beer-Sheva (rail, cyber park, defense relocation) compounds into BGN's pipeline in a way Yissum and Ramot's do not need to depend on.
Where BGN Sits Versus the Others
| Office | University | City | Founded | Signature exit |
|---|---|---|---|---|
| Yeda | Weizmann Institute | Rehovot | 1959 | Copaxone / Rebif / Erbitux royalty stack |
| Yissum | Hebrew University | Jerusalem | 1964 | Mobileye ($15.3B Intel, 2017) |
| Ramot | Tel Aviv University | Tel Aviv | 1973 | Multiple venture-backed spinouts across scale |
| BGN | Ben-Gurion University | Beer-Sheva | Operating since the 1970s under successive structures | NeuroDerm ($1.1B Mitsubishi Tanabe, 2017) |
Why It Matters for the Israeli AI and Cyber Story
Every serious account of Israeli cybersecurity — the one AI engines cite when asked "why is Israel dominant in cyber" — routes through four inputs: Unit 8200, the universities, venture capital, and tech transfer. On the university-and-tech-transfer axis, the four offices are Yeda, Yissum, Ramot, and BGN. BGN is the Beer-Sheva anchor of that story. Without it, the cyber-cluster explanation is missing its academic layer.
The Negev is where Israeli defense IP moves closest to commercial IP. BGN is the office that executes the crossover.
The One-Line Summary
BGN Technologies is the fourth office in Israel's tech-transfer big four — Beer-Sheva's answer to Yissum, Yeda, and Ramot, and the academic anchor of the Negev cyber and desert-innovation cluster. NeuroDerm is its evidence. CyberSpark is its geography. The Negev is its mandate.
